Revision Notes for the Final FRCR Part A: Second Edition
Description:
Revision Notes for the Final FRCR Part A summarises the core knowledge required for each of the six test papers that make up the exam, all in highly succinct bullet point format. The book takes the stress out of the revision process by providing candidates with a readymade set of highly synthesised and relevant notes that focus exclusively on the topics encountered in the exam. Thoroughly updated for the second edition, each chapter has been authored by successful exam candidates and in turn edited by consultant radiologists to provide highly relevant, high quality, high yield revision notes. Key Points * Chapters mirror the structure of the exam: chest & cardiovascular, musculoskeletal and trauma, gastrointestinal & hepatobiliary, paediatrics, genitourinary, gynaecology & breast, and neuroradiology/head & neck * Only essential facts are presented and are based entirely upon past questions from the exam * Each revision topic is presented in a concise manner and exhaustive lists of differential diagnoses have been distilled into those conditions most often tested
Best prices to buy, sell, or rent ISBN 9781909836532
Frequently Asked Questions about Revision Notes for the Final FRCR Part A: Second Edition
The price for the book starts from $52.50 on Amazon and is available from 12 sellers at the moment.
If you’re interested in selling back the Revision Notes for the Final FRCR Part A: Second Edition book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Revision Notes for the Final FRCR Part A: Second Edition book, the best buyback offer comes from and is $ for the book in good condition.
The Revision Notes for the Final FRCR Part A: Second Edition book is in very low demand now as the rank for the book is 10,664,050 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.